A detailed history of Advisor Partners Ii, LLC transactions in Haleon PLC stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 166,658 shares of HLN stock, worth $1.78 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
166,658
Previous 196,038 14.99%
Holding current value
$1.78 Million
Previous $1.64 Million 15.47%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$7.85 - $8.94 $230,633 - $262,657
-29,380 Reduced 14.99%
166,658 $1.39 Million
Q2 2023

Aug 10, 2023

BUY
$8.04 - $9.0 $825,531 - $924,102
102,678 Added 109.98%
196,038 $1.64 Million
Q1 2023

May 15, 2023

BUY
$7.57 - $8.37 $367,288 - $406,104
48,519 Added 108.2%
93,360 $759,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.06 $9,559 - $12,928
1,604 Added 3.71%
44,841 $358,000
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $243,424 - $324,277
43,237 New
43,237 $263,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $49.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.